S&T Bank Abb Vie Inc. Transaction History

S&T Bank

$308 Million
Q4 2024

A detailed history of S&T Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, S&T Bank holds 41,737 shares of ABBV stock, worth $8.43 Million. This represents 2.41% of its overall portfolio holdings.

Number of Shares

41,737

Previous 47,311 11.78%

Holding current value

$8.43 Million

Previous $9.34 Million 20.63%

% of portfolio

2.41%

Previous 2.45%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$164.99 - $203.87 $919,654 - $1.14 Million	-5,574 Reduced 11.78%	41,737 $7.42 Million
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $1.55 Million - $1.88 Million	-9,441 Reduced 16.64%	47,311 $9.34 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $2.23 Million - $2.61 Million	-14,415 Reduced 20.26%	56,752 $9.73 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $1.77 Million - $2.01 Million	-11,057 Reduced 13.45%	71,167 $13 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $462,060 - $520,389	-3,358 Reduced 3.92%	82,224 $12.7 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $394,624 - $456,836	-2,954 Reduced 3.34%	85,582 $12.8 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $799,565 - $995,006	-6,034 Reduced 6.38%	88,536 $11.9 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $859,272 - $989,580	-5,942 Reduced 5.91%	94,570 $15.1 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $142,044 - $170,348	-1,027 Reduced 1.01%	100,512 $16.2 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $362,501 - $415,764	-2,701 Reduced 2.59%	101,539 $13.6 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $1.28 Million - $1.62 Million	-9,272 Reduced 8.17%	104,240 $16 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $495,584 - $614,881	-3,755 Reduced 3.2%	113,512 $18.4 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $153,087 - $193,700	1,425 Added 1.23%	117,267 $15.9 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $873,118 - $991,120	8,206 Added 7.62%	115,842 $12.5 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $472,077 - $525,921	4,487 Added 4.35%	107,636 $12.1 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $258,716 - $284,815	-2,529 Reduced 2.39%	103,149 $11.2 Million
Q4 2020 Feb 17, 2021	SELL	$80.49 - $108.67 $417,823 - $564,105	-5,191 Reduced 4.68%	105,678 $11.3 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $851,969 - $999,931	-9,917 Reduced 8.21%	110,869 $9.71 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $1,320 - $1,767	-18 Reduced 0.01%	120,786 $11.9 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $344,430 - $522,198	-5,340 Reduced 4.23%	120,804 $9.2 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $13,344 - $16,696	185 Added 0.15%	126,144 $11.2 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $7.93 Million - $9.54 Million	125,959 New	125,959 $9.54 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $215,487 - $288,557	-2,342 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $2,776 - $3,044	-31 Reduced 1.31%	2,342 $227,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $165,754 - $211,719	2,373	2,373 $211,000

Others Institutions Holding ABBV

# of Institutions

4,095

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S&T Bank, based on Form 13F filings with the SEC.

News

Stay updated on S&T Bank with notifications on news.

Account